Search

Rajendra S Deshpande

from Placentia, CA
Age ~60
Get Report
Also known as:
Raju Deshpande, Rajen Deshpande, Kajendra Deshpande, Rajendra Desmpande, Cynthia Gaines, Cynthia Butler
Phone and address:
318 Sara Jane Ln, Placentia, CA 92870
(714) 223-6667
Related to:
Amit Arun Deshpande, 49Tracy A Smith, 64Kristina K Smith, 60Shana Brennan, 55Debra L Smith, 57Shawn D Smith, 62Smita R Deshpande, 59Vasanti DeshpandeRohit DeshpandeAbhijit A Deshpande, 61Shashikala DeshpandeRasika R Deshpande, 31Subhash Deshpande, 91
Connected to:
Abhinav Deshpande, 32Achala K Deshpande, 108Anuja Deshpande, 40Anupa V Deshpande, 50Arati V Deshpande, 39Ashwini R Deshpande, 47Avanti V Deshpande, 36Bhushan S Deshpande, 50Chandrakant P Deshpande, 58Deep D Deshpande, 49

Rajendra Deshpande Phones & Addresses

  • 318 Sara Jane Ln, Placentia, CA 92870 (714) 223-6667 (714) 646-9247 (714) 528-8276
  • Temecula, CA
  • 280 Euclid Ave, Pasadena, CA 91101 (626) 577-4458
  • Marlton, NJ
  • Arlington, TX
  • Jersey City, NJ
  • Long Beach, CA
  • North Bergen, NJ
  • 318 Sara Jane Ln, Placentia, CA 92870 (714) 223-6667

Education

Degree: Graduate or professional degree

Resumes

Resumes

Rajendra Deshpande Photo 1

Biopharmaceutical & Medical Device R&D Leader

View page
Location:
Greater Los Angeles Area
Industry:
Pharmaceuticals
Work:
Johnson & Johnson 2010 - 2012
Senior Director, Emerging Technologies, Corporate Office of Science & Technology
Johnson & Johnson 2008 - 2010
Executive Director, Clinical Affairs, Ethicon Endo-Surgery
Amgen 2005 - 2008
Director & Associate Director, Regulatory Affairs
Amgen 2003 - 2005
Associate Director and Senior Manager, R&D Strategic Operations
Amgen 1997 - 2003
Principal, Senior, and Research Scientist
Education:
Medical University of South Carolina 1988 - 1992
Ph.D., Immunology University of Pune 1984 - 1987
M.S., Medical Microbiology & Immunology University of Pune 1981 - 1984
B.S., Microbiology
Skills:
Biopharmaceuticals
Drug Discovery
Drug Development
Regulatory Affairs
Process Excellence
Innovation Management
Medical Devices
Cross-functional Team Leadership
Strategic Alliances
Biotechnology
Rajendra Deshpande Photo 2

Rajendra Deshpande

View page
Rajendra Deshpande Photo 3

Svp/Director Of Change Management, East West Bank

View page
Location:
Orange County, California Area
Industry:
Banking

Publications

Us Patents

Deprotection And Recrystallization Processes

View page
US Patent:
6340752, Jan 22, 2002
Filed:
Dec 9, 1998
Appl. No.:
09/208135
Inventors:
David R. Kronenthal - Yardley PA
Theodor Denzel - Regensburg, DE
James H. Simpson - Belle Mead NJ
Rajendra P. Deshpande - Neshanic Station NJ
Assignee:
Bristol-Myers Squibb Co. - Princeton NJ
International Classification:
C07D28102
US Classification:
540490, 540521, 540523, 544 47, 544 48, 544 90, 544 91
Abstract:
Acylmercaptoalkanoylamino lactam esters or acids are converted to the corresponding mercaptoalkanoylamino lactam ester or acid under basic conditions by including an agent which minimizes the amount of disulfides. Suitable agents are bismercaptans, phosphine or phosphite reducing agents, zinc metal powder, and sodium hydrosulfite. Such agents are also employed in the recrystallization and reprocessing of the mercaptoalkanoylamino lactam acids.

Deprotection Processes

View page
US Patent:
6444810, Sep 3, 2002
Filed:
Nov 16, 2001
Appl. No.:
09/991408
Inventors:
David R. Kronenthal - Yardley PA
Rajendra P. Deshpande - Hillsborough NJ
Assignee:
Bristol-Myers Squibb Co. - Princeton NJ
International Classification:
C07D22312
US Classification:
540527
Abstract:
Acylmercaptoalkanoylamino lactam esters or acids are converted to the corresponding mercaptoalkanoylamino lactam ester or acid under basic conditions by including an agent which minimizes the amount of disulfides. Suitable agents are bismercaptans, phosphine or phosphate reducing agents, zinc metal powder, and sodium hydrosulfite.

Recrystallization Processes

View page
US Patent:
6486315, Nov 26, 2002
Filed:
Nov 16, 2001
Appl. No.:
09/993872
Inventors:
David R. Kronenthal - Yardley PA
Rajendra P. Deshpande - Hillsborough NJ
James Simpson - Hillsborough NJ
Assignee:
Bristol-Myers Squibb Co. - Princeton NJ
International Classification:
C07D22302
US Classification:
540490, 540521, 540523, 540527
Abstract:
Mercaptoalkanoylamino lactam acids are recrystallized by treatment with an agent that minimizes the formation of disulfides. Suitable agents are bismercaptans, phosphine or phosphite reducing agents, zinc metal powder, and sodium hydrosulfite.

Process For Preparing 4-Alkyl- Or 4-Aryl-Oxycarbonyl Paclitaxel Analogs And Novel Intermediates

View page
US Patent:
7030253, Apr 18, 2006
Filed:
Aug 2, 2004
Appl. No.:
10/909899
Inventors:
Frank S. Gibson - Pennington NJ, US
Joydeep Kant - Cherry Hill NJ, US
Rajendra P. Deshpande - Hillsborough NJ, US
Karen L. TenHuisen - Randolph NJ, US
Jing Liang - Princeton NJ, US
Jun Li - Langhorne PA, US
Susan D. Boettger - Fayetteville NY, US
Edward J. Gublo - Liverpool NY, US
Ulhas P. Dhokte - Jamesville NY, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D 305/14
C07F 7/18
US Classification:
549510, 549214
Abstract:
A process is provided for preparing 4-alkyl- or 4-aryl-oxycarbonyl paclitaxel analogs which includes the steps of converting paclitaxel into a C-7 acylprotected paclitaxel employing an electrophilic protecting group, such as benzoyloxycarbonyl, and converting the C-7 protected analog into the 4-alkyloxycarbonyl or 4-aryloxycarbonyl paclitaxel analog. Novel intermediates produced in the process are also provided.
Control profile
Rajendra S Deshpande from Placentia, CA, age ~60 Get Report